← back to search

Julia A. Haller

Palo Alto University · US
Area of research
Ophthalmology · Radiology, Nuclear Medicine and Imaging
Research interest
Research interests include Medicine, Ophthalmology, Macular edema, Visual acuity, Aflibercept, and Diabetic retinopathy.
h-index
citations
4,211
works
22
NIH funding
primary concept
email

Recent publications

Factors Associated With Gonioscopy Coding Before Glaucoma Procedures in the IRISⓇ Registry
American Journal of Ophthalmology 2025cited by 1position: middledoi
Five-Year Outcomes of Lenadogene Nolparvovec Gene Therapy in Leber Hereditary Optic Neuropathy
JAMA Ophthalmology 2024cited by 18position: middledoi
Treatment Patterns of Childhood Glaucoma in the United States: Analysis of IRISⓇ Registry (Intelligent Research in Sight)
American Journal of Ophthalmology 2024cited by 10position: middledoi
The prevalence and recurrence risk of bare sclera pterygium surgery in the United States
The Ocular Surface 2023cited by 6position: middledoi
Randomized trial of bilateral gene therapy injection for m.11778G&amp;gt;A <i>MT-ND4</i> Leber optic neuropathy
Brain 2022cited by 77position: middledoi
Effectiveness of Microinvasive Glaucoma Surgery in the United States
Ophthalmology 2022cited by 39position: middledoi
Indirect Comparison of Lenadogene Nolparvovec Gene Therapy Versus Natural History in Patients with Leber Hereditary Optic Neuropathy Carrying the m.11778G&gt;A MT-ND4 Mutation
Ophthalmology and Therapy 2022cited by 28position: middledoi
Age, Gender, and Laterality of Retinal Vascular Occlusion: A Retrospective Study from the IRIS® Registry
Ophthalmology Retina 2021cited by 51position: middledoi
Representation of Women in Vitreoretinal Meeting Faculty Roles from 2015 through 2019
American Journal of Ophthalmology 2020cited by 19position: lastdoi
Efficacy and safety of voretigene neparvovec (AAV2-hRPE65v2) in patients with RPE65 -mediated inherited retinal dystrophy: a randomised, controlled, open-label, phase 3 trial
The Lancet 2017cited by 1,862position: middledoi
Integrated results from the COPERNICUS and GALILEO studies
Clinical ophthalmology 2017cited by 41position: lastdoi
Five-Year Safety and Performance Results from the Argus II Retinal Prosthesis System Clinical Trial
Ophthalmology 2016cited by 353position: middledoi
Defining a Minimum Set of Standardized Patient-centered Outcome Measures for Macular Degeneration
American Journal of Ophthalmology 2016cited by 114position: middledoi
Patients’ Adherence to Recommended Follow-up Eye Care After Diabetic Retinopathy Screening in a Publicly Funded County Clinic and Factors Associated With Follow-up Eye Care Use
JAMA Ophthalmology 2016cited by 111position: middledoi
A Multi-Center Diabetes Eye Screening Study in Community Settings: Study Design and Methodology
Ophthalmic Epidemiology 2016cited by 14position: middledoi
Long-Term Results from an Epiretinal Prosthesis to Restore Sight to the Blind
Ophthalmology 2015cited by 269position: middledoi
Intravitreal Aflibercept for Macular Edema Following Branch Retinal Vein Occlusion
Ophthalmology 2015cited by 240position: middledoi
Intravitreal Aflibercept for Macular Edema Following Branch Retinal Vein Occlusion
Ophthalmology 2014cited by 380position: lastdoi
INTRAVITREAL INJECTION TECHNIQUE AND MONITORING
Retina 2014cited by 266position: middledoi
Diabetes Eye Screening in Urban Settings Serving Minority Populations
JAMA Ophthalmology 2014cited by 114position: middledoi
OCT-BASED INTERPRETATION OF THE VITREOMACULAR INTERFACE AND INDICATIONS FOR PHARMACOLOGIC VITREOLYSIS
Retina 2013cited by 93position: lastdoi
Effect of the Duration of Macular Edema on Clinical Outcomes in Retinal Vein Occlusion Treated with Dexamethasone Intravitreal Implant
Ophthalmology 2012cited by 105position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

Suzann Pershing · Palo Alto University6 papers (2016–2025)Flora Lum · Luminex (United States)5 papers (2021–2025)Leslie Hyman · Palo Alto University5 papers (2021–2025)Aaron Lee · Imperial College London5 papers (2021–2025)Anja Lorch · L-3 Communications (United States)5 papers (2021–2025)Tobias Elze · Massachusetts Eye and Ear Infirmary5 papers (2021–2025)Joan W. Miller · Amgen (United States)5 papers (2021–2025)Cecilia S. Lee · Stanford University4 papers (2021–2025)David S. Friedman · Massachusetts Eye and Ear Infirmary4 papers (2014–2024)Gerald McGwin · University of Alabama at Birmingham3 papers (2014–2016)W. Lloyd Clark · University of South Carolina3 papers (2014–2017)Jeffrey S. Heier · Wills Eye Hospital3 papers (2013–2015)Nazlee Zebardast · Harvard University3 papers (2022–2025)Cynthia Owsley · University of Alabama at Birmingham3 papers (2014–2016)David S. Boyer · University of Southern California3 papers (2014–2017) · 3 papers (2014–2017)Ta Chen Chang · University of Minnesota2 papers (2024–2025) · 2 papers (2014–2015) · 2 papers (2014–2015)Peter A. Campochiaro · Johns Hopkins University2 papers (2014–2015)